Protocol Ledger

NCT06301165 · Phase II · RECRUITING

TPC Versus GP Induction Chemotherapy for Nasopharyngeal Carcinoma

Interventional Phase II clinical trial protocol NCT06301165 sponsored by Sun Yat-sen University in Oncology and Hematology, reconciled from NIH NLM ClinicalTrials.gov REST API v2.

Start Date: 2024-03-19 Enrollment: 162 participants (ESTIMATED) Federal Source: clinicaltrials.gov/study/NCT06301165
Track in Studio / Generate Client Brief ->
Registered Enrollment vs Phase II/III Median (145 pts)162 participants (ESTIMATED)
Disclosed U.S. Hospital Campuses vs Median (6 sites)4 sites

Reconciled ClinicalTrials.gov v2 Protocol Specification

Structured Registry Fields for NCT06301165
Protocol FieldVerified Registry Value
NCT IdentifierNCT06301165
Consolidated Lead SponsorSun Yat-sen University
Therapeutic Condition CohortOncology and Hematology
Clinical Trial PhasePhase II
Overall Recruitment StatusRECRUITING
Registered Enrollment162 participants (ESTIMATED)
Registered Start Date2024-03-19
WhyStopped ClassificationNot Stopped

Named U.S. Hospital Clinical Research Sites

Search related sites and sponsors in the Interactive Directory, explore Oncology and Hematology Benchmarks, or read the Healthcare Price & Patent Cliff Crosswalk.

Need custom healthcare data pipelines, identifier crosswalks, or workflow automation? Talk to Meru AI